1.
The Impact of Very Late Antigen 4 Polymorphism on Drug Responsiveness in Patients with Multiple Sclerosis Initiation. IRAQI JMS. 2022;20(1). Accessed May 10, 2025. https://iraqijms.net/index.php/jms/article/view/818